Halyard Health Company Profile (NYSE:HYH)

About Halyard Health (NYSE:HYH)

Halyard Health logoHalyard Health, Inc. is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections. The Company address healthcare needs, such as reducing the use of opioids, while helping patients move from surgery to recovery. The Medical Devices segment's products include post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems and enteral feeding tubes. The S&IP segment includes product offerings, such as sterilization wrap, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment, Supplies & Distribution
  • Sub-Industry: N/A
  • Symbol: NYSE:HYH
  • CUSIP: N/A
  • Web: www.halyardhealth.com
Capitalization:
  • Market Cap: $2.13 billion
  • Outstanding Shares: 46,700,000
Average Prices:
  • 50 Day Moving Avg: $43.72
  • 200 Day Moving Avg: $39.69
  • 52 Week Range: $31.59 - $46.36
P/E:
  • Trailing P/E Ratio: 44.12
  • Foreward P/E Ratio: 21.65
  • P/E Growth: 4.93
Sales & Book Value:
  • Annual Revenue: $1.6 billion
  • Price / Sales: 1.33
  • Book Value: $24.77 per share
  • Price / Book: 1.84
Profitability:
  • EBIDTA: $182 million
  • Net Margins: 3.06%
  • Return on Equity: 8.29%
  • Return on Assets: 4.44%
Debt:
  • Debt-to-Equity Ratio: 0.50%
  • Current Ratio: 2.03%
  • Quick Ratio: 1.11%
Misc:
  • Average Volume: 343,272 shs.
  • Beta: 1.76
  • Short Ratio: 11.18
 

Frequently Asked Questions for Halyard Health (NYSE:HYH)

What is Halyard Health's stock symbol?

Halyard Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "HYH."

How were Halyard Health's earnings last quarter?

Halyard Health, Inc. (NYSE:HYH) issued its quarterly earnings results on Wednesday, August, 2nd. The company reported $0.51 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.37 by $0.14. The company had revenue of $399.20 million for the quarter, compared to the consensus estimate of $399.16 million. Halyard Health had a return on equity of 8.29% and a net margin of 3.06%. Halyard Health's revenue was down .2% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.45 EPS. View Halyard Health's Earnings History.

When will Halyard Health make its next earnings announcement?

Halyard Health is scheduled to release their next quarterly earnings announcement on Tuesday, October, 31st 2017. View Earnings Estimates for Halyard Health.

What guidance has Halyard Health issued on next quarter's earnings?

Halyard Health updated its FY18 earnings guidance on Wednesday, August, 2nd. The company provided EPS guidance of $1.85-2.05 for the period, compared to the Thomson Reuters consensus estimate of $2.04.

Where is Halyard Health's stock going? Where will Halyard Health's stock price be in 2017?

4 brokerages have issued 1 year price objectives for Halyard Health's stock. Their forecasts range from $38.00 to $45.00. On average, they expect Halyard Health's stock price to reach $41.67 in the next year. View Analyst Ratings for Halyard Health.

What are analysts saying about Halyard Health stock?

Here are some recent quotes from research analysts about Halyard Health stock:

  • 1. According to Zacks Investment Research, "Halyard Health, Inc. is a medical technology company. It is focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company sells surgical and infection prevention products for the operating room. Halyard offers products such as sterilization wraps, face masks, surgical drapes and gowns, closed suction catheters, pain pumps and enteral feeding tubes. It offers a range of medical device solutions including post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems, and enteral feeding tubes. Halyard Health, Inc. is headquartered in Alpharetta, Georgia. " (7/12/2017)
  • 2. Stifel Nicolaus analysts commented, "HYH closed 2016 with its fourth consecutive quarter of sales and EPS upside relative to both Consensus and management guidance. After a more difficult than expected first-year (2015) post-spin, in 2016, the company's transformation took clearer shape and was highlighted by: accretive M&A, a positive mix shift to the more profitable Medical Device franchise (38% of sales; 64% of operating profit), successful re-negotiations of material GPO contracts, significant organic cost-savings and stepped-up investments, all with significantly improved cash flow generation ($100M+ guide vs. $160M actual). We continue to believe HYH has further price appreciation potential ahead as '2016-like' thematic drivers continue playing out over the next 12-24 months. Still, we acknowledge that HYH shares (+56% TTM vs. S&P500: +23%) trading at 20x 2018E EPS (vs. large cap ~18x) could "pause" here as the stock absorbs the recent out-performance and the next wave of potentially positive catalysts becomes more visible. Yet to be realized sales, margin, and EPS-enhancing catalysts could include: IT cost savings, better S&IP pricing, more normal nitrile pricing and most important, further accretive M&A opportunities. Company-specific 2017 headwinds could include: more intense commodity price inflation, stepped up On-Q competition, and still uncertain macro tax-related legislation. For us, the bottom line is that HYH remains a positive long-term transformation story that is still in 'early innings' with significant opportunity both organically and through acquisitions to leverage earnings. We rate HYH Buy and raise our TP to $45 (from $38)." (2/28/2017)

Who are some of Halyard Health's key competitors?

Who are Halyard Health's key executives?

Halyard Health's management team includes the folowing people:

  • Robert E. Abernathy, Chairman of the Board
  • Joseph F. Woody, Chief Executive Officer, Director
  • Steven E. Voskuil, Chief Financial Officer, Senior Vice President
  • Christopher M. Lowery, Chief Operating Officer, Senior Vice President
  • Rhonda D. Gibby, Chief Human Resource Officer, Senior Vice President
  • John W. Wesley, Senior Vice President, General Counsel
  • Christopher G. Isenberg, Senior Vice President - Global Supply Chain and Procurement
  • Warren J. Machan, Senior Vice President - Business Strategy
  • Ronald W. Dollens, Chairman of the Board
  • Gary D. Blackford, Independent Director

Who owns Halyard Health stock?

Halyard Health's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (11.32%), Vanguard Group Inc. (9.03%), Dimensional Fund Advisors LP (6.70%), Goldman Sachs Group Inc. (3.98%), State Street Corp (3.64%) and Paradice Investment Management LLC (3.28%). View Institutional Ownership Trends for Halyard Health.

Who sold Halyard Health stock? Who is selling Halyard Health stock?

Halyard Health's stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Cove Street Capital LLC, Vanguard Group Inc., Gotham Asset Management LLC, Wells Fargo & Company MN, Cornerstone Capital Management Holdings LLC., Convergence Investment Partners LLC and GSA Capital Partners LLP. View Insider Buying and Selling for Halyard Health.

Who bought Halyard Health stock? Who is buying Halyard Health stock?

Halyard Health's stock was bought by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Dimensional Fund Advisors LP, Northern Trust Corp, Koch Industries Inc., JPMorgan Chase & Co., State Street Corp, Paradice Investment Management LLC and AXA. View Insider Buying and Selling for Halyard Health.

How do I buy Halyard Health stock?

Shares of Halyard Health can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Halyard Health's stock price today?

One share of Halyard Health stock can currently be purchased for approximately $45.68.


MarketBeat Community Rating for Halyard Health (NYSE HYH)
Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  122 (Vote Outperform)
Underperform Votes:  121 (Vote Underperform)
Total Votes:  243
MarketBeat's community ratings are surveys of what our community members think about Halyard Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Halyard Health (NYSE:HYH) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $41.67 (8.79% downside)

Analysts' Ratings History for Halyard Health (NYSE:HYH)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/21/2017Stifel NicolausReiterated RatingBuy$45.00LowView Rating Details
8/3/2017Deutsche Bank AGBoost Price TargetBuy$35.00 -> $42.00MediumView Rating Details
8/3/2017StephensUpgradeEqual Weight -> OverweightMediumView Rating Details
1/6/2017JMP SecuritiesDowngradeOutperform -> Market Perform$38.00N/AView Rating Details
12/18/2015KeyCorpInitiated CoverageSector WeightN/AView Rating Details
10/12/2015Morgan StanleyDowngradeEqual Weight -> Underweight$27.00N/AView Rating Details
(Data available from 9/26/2015 forward)

Earnings

Earnings History for Halyard Health (NYSE:HYH)
Earnings by Quarter for Halyard Health (NYSE:HYH)
Earnings History by Quarter for Halyard Health (NYSE HYH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/31/2017$0.47N/AView Earnings Details
8/2/2017Q2 2017$0.37$0.51$399.16 million$399.20 millionViewListenView Earnings Details
5/2/2017Q1 2017$0.43$0.48$391.56 million$395.60 millionViewListenView Earnings Details
2/27/2017Q416$0.44$0.50$401.72 million$410.00 millionViewListenView Earnings Details
11/2/2016Q316$0.39$0.48$387.64 million$398.00 millionViewN/AView Earnings Details
8/3/2016Q216$0.36$0.45$383.08 million$400.00 millionViewN/AView Earnings Details
5/4/2016Q116$0.34$0.53$369.80 million$385.00 millionViewN/AView Earnings Details
2/29/2016Q415$0.50$0.57$401.96 million$401.40 millionViewListenView Earnings Details
11/3/2015Q315$0.47$0.52$388.00 million$390.00 millionViewN/AView Earnings Details
8/4/2015Q215$0.53$0.52$401.70 million$389.30 millionViewN/AView Earnings Details
5/4/2015Q1 2015$0.64$0.51$390.00 million$394.00 millionViewN/AView Earnings Details
3/4/2015Q4$0.75$1.59$425.10 million$439.40 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Halyard Health (NYSE:HYH)
2017 EPS Consensus Estimate: $1.80
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.44$0.44$0.44
Q2 20171$0.40$0.40$0.40
Q3 20171$0.47$0.47$0.47
Q4 20171$0.49$0.49$0.49
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Halyard Health (NYSE:HYH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Halyard Health (NYSE:HYH)
Insider Ownership Percentage: 1.30%
Institutional Ownership Percentage: 91.02%
Insider Trades by Quarter for Halyard Health (NYSE:HYH)
Institutional Ownership by Quarter for Halyard Health (NYSE:HYH)
Insider Trades by Quarter for Halyard Health (NYSE:HYH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/4/2015Robert E AbernathyCEOBuy10,000$31.06$310,600.00View SEC Filing  
9/1/2015Steven E VoskuilCFOBuy1,000$30.00$30,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Halyard Health (NYSE:HYH)
Latest Headlines for Halyard Health (NYSE:HYH)
Source:
DateHeadline
americanbankingnews.com logoHalyard Health, Inc. (HYH) Rating Reiterated by Stifel Nicolaus
www.americanbankingnews.com - September 21 at 11:24 AM
finance.yahoo.com logoHalyard Health (HYH) Announces Positive Data on COOLIEF
finance.yahoo.com - September 20 at 4:02 PM
prnewswire.com logoHalyard Health Announces New Data Supporting COOLIEF* Cooled ... - PR Newswire (press release)
www.prnewswire.com - September 19 at 12:13 AM
finance.yahoo.com logoHalyard Health Announces New Data Supporting COOLIEF* Cooled RF for the Treatment of Chronic Osteoarthritis Knee Pain
finance.yahoo.com - September 18 at 7:11 PM
seekingalpha.com logoHalyard Health's (HYH) Presents at Morgan Stanley Global Healthcare Conference (Transcript) - Seeking Alpha
seekingalpha.com - September 14 at 6:16 AM
americanbankingnews.com logoZacks: Analysts Anticipate Halyard Health, Inc. (HYH) Will Announce Earnings of $0.48 Per Share
www.americanbankingnews.com - September 9 at 2:28 PM
prnewswire.com logoHalyard Health, Inc. to Present at Morgan Stanley Global Healthcare Conference - PR Newswire (press release)
www.prnewswire.com - September 8 at 12:53 AM
americanbankingnews.com logoHalyard Health, Inc. (HYH) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - September 6 at 8:44 PM
finance.yahoo.com logoHalyard Health Introduces Five New COOLIEF* Multi-Cooled RF Kits
finance.yahoo.com - September 6 at 7:37 PM
finance.yahoo.com logoHalyard Health, Inc. to Present at Morgan Stanley Global Healthcare Conference
finance.yahoo.com - September 6 at 6:14 AM
americanbankingnews.com logoReviewing Halyard Health (HYH) and NuVasive (NUVA)
www.americanbankingnews.com - September 4 at 10:18 AM
americanbankingnews.com logoZacks: Analysts Anticipate Halyard Health, Inc. (HYH) Will Post Quarterly Sales of $397.61 Million
www.americanbankingnews.com - August 24 at 10:42 AM
americanbankingnews.com logoHalyard Health, Inc. (HYH) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - August 19 at 6:28 PM
americanbankingnews.com logoHalyard Health, Inc. (HYH) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - August 12 at 8:34 PM
zacks.com logoTop Ranked Momentum Stocks to Buy for August 8th
www.zacks.com - August 10 at 12:58 AM
finance.yahoo.com logoSee what the IHS Markit Score report has to say about Halyard Health Inc.
finance.yahoo.com - August 9 at 7:54 PM
seekingalpha.com logoHalyard Health: As Shares Surge To 52-Week Highs, Transformation Will Continue - Seeking Alpha
seekingalpha.com - August 8 at 7:23 PM
americanbankingnews.com logoQ4 2017 EPS Estimates for Halyard Health, Inc. Cut by KeyCorp (HYH)
www.americanbankingnews.com - August 7 at 7:28 AM
americanbankingnews.com logoHalyard Health, Inc. (NYSE:HYH) Expected to Post Quarterly Sales of $395.18 Million
www.americanbankingnews.com - August 5 at 7:08 AM
finance.yahoo.com logoHalyard Health, Inc. Announces Second Quarter 2017 Results, Raises Full-Year Adjusted Diluted EPS Outlook
finance.yahoo.com - August 4 at 7:57 PM
finance.yahoo.com logoInvestor Network: Halyard Health Inc to Host Earnings Call
finance.yahoo.com - August 4 at 7:57 PM
americanbankingnews.com logoHead-To-Head Comparison: Halyard Health (NYSE:HYH) vs. Integra LifeSciences Holdings Corporation (IART)
www.americanbankingnews.com - August 4 at 7:52 AM
americanbankingnews.com logoResearch Analysts Set Expectations for Halyard Health, Inc.'s Q3 2017 Earnings (NYSE:HYH)
www.americanbankingnews.com - August 4 at 7:42 AM
finance.yahoo.com logoEdited Transcript of HYH earnings conference call or presentation 2-Aug-17 1:00pm GMT
finance.yahoo.com - August 4 at 12:46 AM
seekingalpha.com logoHalyard Health target of 60 Minutes report on allegedly providing faulty surgical gowns to US hospitals; investors ... - Seeking Alpha
seekingalpha.com - August 3 at 7:44 PM
seekingalpha.com logoHalyard Health's (HYH) CEO Joseph Woody on Q2 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - August 2 at 8:17 PM
finance.yahoo.com logoHalyard tops 2Q profit forecasts
finance.yahoo.com - August 2 at 8:16 PM
americanbankingnews.com logoHalyard Health, Inc. (HYH) Announces Quarterly Earnings Results
www.americanbankingnews.com - August 2 at 3:02 PM
americanbankingnews.com logoHalyard Health, Inc. (HYH) Updates FY18 Earnings Guidance
www.americanbankingnews.com - August 2 at 9:52 AM
prnewswire.com logoHalyard Health, Inc. To Webcast Conference Call Discussing Second Quarter 2017 Financial Results - PR Newswire (press release)
www.prnewswire.com - July 28 at 10:43 PM
finance.yahoo.com logoHalyard Health, Inc. To Webcast Conference Call Discussing Second Quarter 2017 Financial Results
finance.yahoo.com - July 26 at 4:07 PM
americanbankingnews.com logoHalyard Health, Inc. (HYH) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - July 18 at 8:47 PM
americanbankingnews.com logo$400.37 Million in Sales Expected for Halyard Health, Inc. (NYSE:HYH) This Quarter
www.americanbankingnews.com - July 14 at 1:24 PM
americanbankingnews.com logoZacks: Brokerages Expect Halyard Health, Inc. (NYSE:HYH) Will Post Earnings of $0.38 Per Share
www.americanbankingnews.com - July 12 at 4:16 PM
americanbankingnews.com logoHalyard Health, Inc. (HYH) Downgraded by BidaskClub to Hold
www.americanbankingnews.com - July 8 at 6:32 PM
seekingalpha.com logoHalyard Health: Is A Major Divestiture In The Works? - Seeking Alpha - Seeking Alpha
seekingalpha.com - July 1 at 12:47 AM
americanbankingnews.com logoICU Medical (ICUI) and Halyard Health (HYH) Head to Head Analysis
www.americanbankingnews.com - June 28 at 6:28 PM
americanbankingnews.com logoHalyard Health, Inc. (HYH) Upgraded to Buy at BidaskClub
www.americanbankingnews.com - June 28 at 6:14 PM
finance.yahoo.com logoCorporate News Blog - Halyard Health Views CEO Transition; Robert Abernathy Replaced by Joseph Woody from Acelity
finance.yahoo.com - June 26 at 7:35 PM
americanbankingnews.com logoHalyard Health, Inc. (HYH) Stock Rating Upgraded by TheStreet
www.americanbankingnews.com - June 25 at 11:40 PM
prnewswire.com logoHalyard Health Announces CEO Transition - PR Newswire (press release)
www.prnewswire.com - June 24 at 6:10 PM
americanbankingnews.com logoHalyard Health, Inc. (HYH) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - June 23 at 6:34 PM
streetinsider.com logoHalyard Health (HYH) CEO Robert Abernathy to Retire; Board Appoints Joseph Woody as CEO Successor
www.streetinsider.com - June 23 at 6:02 PM
finance.yahoo.com logoHalyard Health Announces CEO Transition
finance.yahoo.com - June 23 at 6:02 PM
finance.yahoo.com logoAtlanta's Halyard Health names new CEO, who's getting $1M sign-on award
finance.yahoo.com - June 23 at 6:02 PM
americanbankingnews.com logo Analysts Anticipate Halyard Health, Inc. (HYH) Will Post Quarterly Sales of $400.37 Million
www.americanbankingnews.com - June 18 at 8:55 AM
americanbankingnews.com logo Analysts Expect Halyard Health, Inc. (HYH) Will Post Earnings of $0.39 Per Share
www.americanbankingnews.com - June 16 at 4:42 PM
finance.yahoo.com logoETFs with exposure to Halyard Health, Inc. : June 15, 2017
finance.yahoo.com - June 15 at 8:02 PM
reuters.com logoHalyard Health explores sale of hospital product unit: sources - Reuters
www.reuters.com - June 13 at 10:36 PM
reuters.com logoHalyard Health explores sale of hospital product unit: sources
www.reuters.com - June 12 at 6:26 PM

Social

Chart

Halyard Health (HYH) Chart for Tuesday, September, 26, 2017

This page was last updated on 9/26/2017 by MarketBeat.com Staff